CardioVascular BioTherapeutics (fka CVBT)

[johnnymcgriffin347]

DAN MONTANO STARTED THE CLINICAL TRIALS FOR CVBT

The members of this board are quick to argue that the former leadership has failed completely. On the contrary, the same clinical trails that our leadership touts as successes were started by Dan Montano, and have yet to move since Dan Montano left the company in 2014. The CVBT/Venturis Therapeutics leadership has been advertising their success from the past successes of Dan Montano, who now is successfully running Zhittya Genesis Medicine which has now created new FGF-1 and is starting clinical trials.

I cannot point to a single thing our leadership has done in the past 7 years that are on par with Phase II clinical trials which Venturis Therapeutics inherited from Dan Montano's efforts. What have we done in the last seven years other than IP?